Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125400671 | 12540067 | 1 | I | 20160503 | 0 | 20160707 | 20160707 | DIR | 59.00 | YR | F | N | 123.00000 | LBS | 20160706 | N | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125400671 | 12540067 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | Y | 20161101 | 0 | 90 | DF | COATED TABLET | HS | ||||
125400671 | 12540067 | 3 | C | ANGELIQUE | 2 | 0 | |||||||||||||
125400671 | 12540067 | 5 | C | BUDESONIDE. | BUDESONIDE | 1 | 0 | ||||||||||||
125400671 | 12540067 | 7 | C | FLUNISONIDE | 2 | 0 | |||||||||||||
125400671 | 12540067 | 9 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
125400671 | 12540067 | 11 | C | MULTI-VITAMIN | .ALPHA.-TOCOPHEROL ACETATE, DL-ASCORBIC ACIDCYANOCOBALAMINFLUORIDE IONFOLIC ACIDNIACINPYRIDOXINERIBOFLAVINTHIAMINEVITAMIN AVITAMIN D | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125400671 | 12540067 | 1 | Blood cholesterol increased |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125400671 | 12540067 | DS |
125400671 | 12540067 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125400671 | 12540067 | Amnesia | |
125400671 | 12540067 | Anxiety | |
125400671 | 12540067 | Back pain | |
125400671 | 12540067 | Breast pain | |
125400671 | 12540067 | Confusional state | |
125400671 | 12540067 | Constipation | |
125400671 | 12540067 | Depression | |
125400671 | 12540067 | Discomfort | |
125400671 | 12540067 | Disorientation | |
125400671 | 12540067 | Dysphonia | |
125400671 | 12540067 | Dyspnoea | |
125400671 | 12540067 | Dystonia | |
125400671 | 12540067 | Fatigue | |
125400671 | 12540067 | Feeling abnormal | |
125400671 | 12540067 | Gastrooesophageal reflux disease | |
125400671 | 12540067 | Headache | |
125400671 | 12540067 | Muscle disorder | |
125400671 | 12540067 | Muscular weakness | |
125400671 | 12540067 | Musculoskeletal pain | |
125400671 | 12540067 | Myalgia | |
125400671 | 12540067 | Nausea | |
125400671 | 12540067 | Neck pain | |
125400671 | 12540067 | Night sweats | |
125400671 | 12540067 | Pain in jaw | |
125400671 | 12540067 | Quality of life decreased | |
125400671 | 12540067 | Spinal pain | |
125400671 | 12540067 | Tinnitus | |
125400671 | 12540067 | Toothache | |
125400671 | 12540067 | Vitreous floaters |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125400671 | 12540067 | 1 | 20150202 | 20160519 | 0 |